Magnetic resonance imaging in the diagnosis of nonpalpable breast cancer

Cover Page

Cite item


Aim. To analyze sensitivity of magnetic resonance imaging (MRI) in the diagnosis of breast cancer when used after mammography and breast ultrasound.

Methods. The study included 70 patients with nonpalpable breast lesions who had changes of breast tissue found at previous studies (mammography and breast ultrasound). MRI was performed with the use of Siemens Magnetom Avanto with magnetic field 1.5 Tl.

Results. Most frequently nonpalpable lesions were diagnosed in 45 to 60-year old patients (60%), a little rarer - in 39 to 45-year old patients (22.9%), in patients at the age of 61 to 69 - in 10.0% (7 patients). 7.1% patients were over 70. All first detected nonpalpable lesions of breast were biopsied for morphological verification. With the combined use of mammography, sonography, MRI and stereotactic biopsy the diagnosis was made in 100% patients. MRI with contract enhancement showed no relation between sensitivity, specificity and reliability and density of breast tissues.

Conclusions. MRI is considered a highly sensitive method of diagnosis and identification of changes found at mammography and breast ultrasound.

About the authors

S S Vatankha

National Cancer center

Author for correspondence.

S A Saryev

National Cancer center



  1. Алиев Д.А., Джафаров Р.Д., Наджафов Т.А. и др. Сравнительное изучение показателей 5-летней выживаемости у больных люминальным А и люминальным Б РМЖ. Azərbaycan onkologiya və hematologiya jurnalı. 2014; (1): 102-104.
  2. Берштейн Л.М. Рак гормонозависимых тканей в системе основных неинфекционных заболеваний человека. СПб.: Эскулап. 2009; 180 с.
  3. Бойков И.В. Руководство по лучевой диагностике заболеваний молочных желёз. Под ред. Г.Е. Труфанова. СПб.: ЭЛБИ-СПб. 2009; 351 с.
  4. Куликов Е.П., Загадаев А.П. Непальпириумые опухоли молочных желёз. М.: ГЭОТАР-Медиа. 2013; 152 с.
  5. Мальчугина Е.Л., Диомидова В.Н., Агафонкина Т.В. Маммосцинтиграфия в алгоритме лучевой диагностики рака молочной железы. Вестн. Чуваш. гос. ун-та. 2013; (3): 320-327.
  6. Труфанов Г.Е. Руководство по лучевой диагностике заболеваний молочных желёз. СПб.: ЭЛСБИ-СПб. 2009; 229 с.
  7. Kim S.J., Tanei T., Morimoto K. et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin. Cancer Res. 2009; 15: 4234-4241. doi: 10.1158/1078-0432.CCR-08-1479
  8. Lee J., Choi H. Diffusion-weighted imaging in breast malignancies: Comparison of different b-value. Eur. Radiology. 2008; 18 (1): 96.
  9. Lopez J., Bassett L. Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings. Radiographics. 2009; (1): 165-176. doi: 10.1148/rg.291085100
  10. Peters N.H., Borel Rinkes I.H., Mali W.P. et al. Breast MRI in nonpalpable breast lesions: a randomized trial with diagnostic and therapeutic outcome - MONET - study. Radiology. 2007; 8: 149-155. doi: 10.1186/1745-6215-8-40
  11. Peters N.H., Borel Rinkes I.H., Zuithoff N.P. et al. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008; 246: 116-124. doi: 10.1148/radiol.2461061298
  12. Əliyev C.Ə., İsayev İ.H. Bəd xassəli şişlərin şüa müalicəsi: nəzəri əsasları, tətbiqi, nəticələri. Bakı. 2012; 890 s.

© 2017 Vatankha S.S., Saryev S.A.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies